Introduction to ERAS for Glioma Craniotomy

Enhanced recovery after surgery protocols have transformed modern surgical care across multiple subspecialties. However, evidence supporting ERAS for glioma craniotomy remains limited in neuro-oncology practice. Surgical teams historically relied on rigid traditional perioperative care pathways, which often prolonged patient recovery and increased hospital stay. Brain tumor surgery presents unique challenges, including cerebral edema, postoperative neurological deficits, and complex cognitive considerations. Consequently, clinicians hesitated to adopt fast-track recovery protocols for neurosurgical procedures. Recent clinical research now highlights how standardized perioperative pathways can safely streamline recovery for patients undergoing brain tumor resection. Implementing ERAS for glioma craniotomy optimizes perioperative care through multimodal interventions that minimize physiological stress responses. These clinical pathways integrate preoperative optimization, intraoperative fluid management, and rapid postoperative mobilization. Early findings indicate that structured pathways significantly improve clinical efficiency without increasing complication rates. Neurosurgeons and anesthesiologists can now utilize evidence-based protocols to enhance functional outcomes. Understanding these advancements allows surgical teams to modernize perioperative protocols effectively while maintaining patient safety.

Study Design and Methodology Behind the Research

To evaluate these outcomes, investigators conducted a retrospective cohort study at a Thai university hospital from 2019 to 2024. The research evaluated adult patients aged fifteen years or older undergoing elective craniotomy for a single cerebral glioma. Researchers compared outcomes between patients managed under an institutional ERAS pathway and those receiving conventional perioperative care. To eliminate baseline confounding factors, investigators performed propensity score matching at a one-to-one ratio. This analytical method yielded fifty-three matched pairs from an initial eligible cohort of one hundred fifty-three patients. Additionally, researchers performed inverse probability of treatment weighting as a robust sensitivity analysis. The study focused on primary endpoints including total hospital length of stay, intensive care unit length of stay, and postoperative stay. Secondary outcomes evaluated total hospitalization costs and overall complication rates between both cohorts. By utilizing propensity score matching, the authors effectively minimized selection bias, ensuring high scientific validity. Consequently, the study provides robust real-world data regarding the safety and efficacy of fast-track neurosurgical pathways.

Key Findings on Hospital and Postoperative Stay

The statistical analysis demonstrated significant clinical benefits for patients enrolled in the specialized pathway. Specifically, patients receiving ERAS for glioma craniotomy experienced a shorter median total hospital stay of nine days compared to twelve days in conventional care. Furthermore, median postoperative length of stay dropped significantly from nine days down to seven days. The inverse probability of treatment weighting sensitivity analysis further confirmed these directionally consistent findings. Importantly, intensive care unit length of stay remained equivalent between both patient groups. Additionally, total hospitalization costs and overall complication rates showed no significant differences between the two study arms. These findings demonstrate that accelerating recovery does not compromise patient safety or increase adverse event rates. Therefore, structured perioperative pathways effectively optimize hospital resource utilization without compromising clinical safety. Patients achieve faster functional recovery while surgical teams maintain high standards of patient care. Overall, the research reinforces the overall safety profile of modern fast-track neurosurgical management.

Specific Predictors for Reduced Hospitalization

Beyond evaluating overall cohort outcomes, the researchers conducted multivariable logistic regression analyses to identify specific independent predictors of reduced stay. The analysis identified two specific interventions that strongly predicted a short postoperative length of stay under seven days. Preoperative carbohydrate loading administered two hours before surgery independently increased the odds of early discharge nearly sixfold. Similarly, encouraging early oral fluid intake within eight hours postoperatively independently predicted shorter hospital stay with a similar strength of association. These specific components effectively reduce surgical stress, maintain metabolic homeostasis, and prevent postoperative nausea. Furthermore, early oral hydration promotes intestinal motility and enhances patient comfort immediately following anesthesia. Consequently, targeted perioperative interventions significantly accelerate functional recovery in neurosurgical patients. Clinical teams can easily prioritize these non-invasive measures during pathway implementation. Emphasizing these two elements provides immediate clinical benefit with minimal financial or logistical burden on healthcare facilities.

Clinical Implications for Modern Perioperative Care

These findings offer valuable clinical guidance for neurosurgeons, anesthesiologists, and nursing staff managing neuro-oncology cases. Traditional neurosurgical management frequently enforced prolonged fasting periods and restricted early postoperative oral intake. However, modern clinical evidence confirms that structured metabolic support and early rehydration significantly improve patient recovery metrics. By implementing preoperative carbohydrate loading, clinicians minimize insulin resistance and preserve cellular energy stores during major surgery. Additionally, early oral fluid administration reduces the need for prolonged intravenous hydration, allowing earlier catheter removal and patient mobilization. These protocol modifications lower the risk of hospital-acquired complications while boosting patient satisfaction and independence. Importantly, achieving equivalent intensive care unit stays and complication rates reassures clinicians regarding safety concerns. Therefore, multidisciplinary surgical teams can confidently adopt enhanced recovery principles in routine cranial surgery. Establishing clear perioperative protocols optimizes clinical workflows and aligns neurosurgical practice with international standards of care.

Stepwise Implementation Strategies for Surgical Teams

Implementing a full enhanced recovery protocol requires coordinated multidisciplinary collaboration and structured organizational planning. Given the complexity of neurosurgical care, institutions may benefit from a pragmatic, stepwise implementation strategy. Surgical departments should initially focus on high-priority interventions with proven high-impact results, such as preoperative carbohydrate loading and early oral fluid administration. Once teams successfully integrate these fundamental elements, additional protocol components can be systematically incorporated. Furthermore, continuous audit of protocol adherence and clinical outcomes remains essential for long-term program sustainability. Staff education across neurosurgical wards, operating theaters, and intensive care units ensures smooth transitions and high compliance. Engaging patients through comprehensive preoperative education also empowers them to participate actively in their recovery process. Ultimately, adopting evidence-based fast-track pathways enhances healthcare quality, shortens hospital stays, and optimizes resource allocation across neurosurgical centers worldwide.

Frequently Asked Questions

What are the primary benefits of ERAS for glioma craniotomy?

Implementing ERAS for glioma craniotomy significantly reduces total hospital length of stay and postoperative recovery time. Crucially, the protocol achieves these clinical improvements without increasing intensive care unit duration, overall hospitalization costs, or postoperative complication rates, demonstrating both safety and therapeutic efficacy for neurosurgical patients.

Which key interventions most strongly predict shorter postoperative stay?

Multivariable regression analysis identified two specific high-value interventions: preoperative carbohydrate loading administered two hours before surgery and early oral fluid intake within eight hours postoperatively. Both measures independently predicted a short postoperative hospital stay of under seven days with nearly sixfold increased odds.

Is early oral fluid intake safe after elective brain tumor surgery?

Yes, early oral fluid intake within eight hours postoperatively is safe and highly beneficial for selected elective glioma patients. It enhances patient comfort, supports physiological recovery, and independently predicts shorter postoperative hospitalization without increasing the risk of adverse clinical outcomes or surgical complications.

Disclaimer: This content is for informational and educational purposes only, and should not be considered medical advice. Refer to the latest local and national guidelines for clinical practice.

References

1. Punyasiri R et al. Enhanced recovery after surgery (ERAS) for elective glioma craniotomy: a propensity score-matched retrospective cohort study. Neurosurg Rev. 2026 Aug 06. doi: 10.1007/s10143-026-04439-y. PMID: 42560602.

2. Royal College of Surgeons. Guidelines for perioperative care in neurosurgery and enhanced recovery pathways. 2024.